Uncategorized

Read the Indian IVD market report prepared by Sanstrat Research Team.

Watch this candid conversation between Abhinav Thakur, Managing Director, Accurex Biomedical and our Founder, Sangeeth Kini.This Podcast series brings in the Leaders of the In-Vitro Diagnostic Industry, to seek their unique perspectives on a wide range of topics. Watch this space for more such podcasts.

SANSTRAT Announces the Launch of India’s First Strategic Advisory Firm Focused Exclusively on the IVD Sector Bangalore, India — Sanstrat is excited to announce its official launch as the only strategic advisory firm in India dedicated exclusively to the In Vitro Diagnostics (IVD) sector. With a specific focus on supporting global companies to establish and

The Indian In-Vitro Diagnostic (IVD) industry has been on a robust growth trajectory, expanding at an average rate of 15% annually over the past 30 years. By 2025, the market size for IVD products in India is projected to reach USD 1.5 billion. This vibrant market is home to over a hundred IVD companies, from

Point-of-care testing (POCT) refers to diagnostic testing that takes place near the patient, typically in settings like a doctor’s office/clinic  or hospital, with results available within minutes. The goal is to deliver faster results, which facilitates quicker decision-making regarding treatment. The Indian Point-of-Care (POC) testing market is experiencing significant growth, expanding at an annual rate

https://economictimes.indiatimes.com/news/economy/foreign-trade/india-eu-trade-put-firmly-on-track-big-news-expected-within-this-year/articleshow/118619078.cms? Optimism in the air !As trade barriers break, technology becomes accessible ! In-Vitro Diagnostic companies across India and EU would benefit from easier access to each others market. This benefits the patients as well as the health care professional who would be able to access newer technology for earlier and accurate diagnosis. India is